The Journal of Immunology, Vol 146, Issue 6 1900-1908, Copyright © 1991 by American Association of Immunologists

ARTICLES

The presence of sialidase-sensitive sialosylgangliotetraosyl ceramide (GM1b) in stimulated murine macrophages. Deficiency of GM1b in Escherichia coli-activated macrophages from the C3H/HeJ mouse

HC Yohe, CL Cuny, LJ Macala, M Saito, WJ McMurray and JL Ryan
Infectious Disease Section, Yale University School of Medicine, Veterans Administration Medical Center, West Haven, CT 06516.

The stimulated murine macrophage was found to contain 11 major gangliosides of which 8 were determined to be monosialylated. The thin- layer chromatographic patterns were complicated by the presence of both sialic acid and ceramide fatty acid heterogeneity. N-glycolyl and N- acetylneuraminic acid-containing species were present for each ganglioside characterized. Although C18 sphingosine was the only long chain base detected, ceramide fatty acid ranged from C16 to C24 carbon moieties. Based on gas-liquid chromatographic and antibody analyses, all major tetraosyl structure gangliosides were ganglio series types. Comprising 43 to 60% of thioglycollate-stimulated cells and 60 to 70% of Escherichia coli-activated cells, monosialosyl-gangliotetraosyl ceromides (Gm1 gangliosides) were the major monosialo species of which four were present: sialidase-resistant NeuGc-GM1a and NeuAc-GM1a and sialidase sensitive NeuGc-GM1b and NeuAc-GM1b. Analyses of thioglycollate-elicited murine peritoneal macrophage ganglioside patterns from four strains of mice, including the C3H/HeJ strain, indicated that, in the absence of any expression of a genetic defect, the pattern is conserved. However, when E. coli was used as the activating agent, the normal C3H/HeN macrophage contained little Gm1a with the sialidase-sensitive Gm1b predominant; the converse was true for the congenic endotoxin hyporesponsive C3H/HeJ strain. Therefore, C3H/HeJ mice are not defective in ganglioside metabolism per se but in the processing of an endotoxin stimulus such that one manifestation is an altered macrophage ganglioside pattern deficient in Gm1b.

This article has been cited by other articles:

				C. S. Berenson, M. A. Gallery, J. M. Smigiera, and R. H. Rasp The role of ceramide of human macrophage gangliosides in activation of human macrophages J. Leukoc. Biol., September 1, 2002; 72(3): 492 - 502. [Abstract] [Full Text] [PDF]

				H. C. Yohe, P. K. Wallace, C. S. Berenson, S. Ye, B. B. Reinhold, and V. N. Reinhold The major gangliosides of human peripheral blood monocytes/macrophages: absence of ganglio series structures Glycobiology, October 1, 2001; 11(10): 831 - 841. [Abstract] [Full Text] [PDF]

				C. S. Berenson, R. H. Rasp, J.-T. Gau, J. L. Ryan, and H. C. Yohe Differences in splenic B-lymphocyte ganglioside expression and accessibility in normal and endotoxin-hyporesponsive mice J. Leukoc. Biol., June 1, 2001; 69(6): 969 - 976. [Abstract] [Full Text] [PDF]

				H. C. Yohe and M. E. Griffin Reduction of asialo pathway gangliosides in Escherichia coli-activated peritoneal macrophages from endotoxin hyporesponsive mice Innate Immunity, December 1, 1997; 4(6): 401 - 408. [Abstract] [PDF]

				N. Thieblemont and S. D. Wright Mice Genetically Hyporesponsive to Lipopolysaccharide (LPS) Exhibit a Defect in Endocytic Uptake of LPS and Ceramide J. Exp. Med., June 16, 1997; 185(12): 2095 - 2100. [Abstract] [Full Text] [PDF]